The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder
Clinical trial NCT00418184 · COMPLETED
Trial details
- NCT number
- NCT00418184
- Sponsor
- Enzymotec
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2008-11-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.